Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Safety Profile of Tozorakimab (an Anti-IL-33 Monoclonal Antibody): Data from the FRONTIER Phase 2 Program
Saved in:
| Published in: | Biologics: Targets & Therapy |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1871928171038769155 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Biologics: Targets & Therapy |
| description | |
| discipline_display | Biology |
| discipline_facet | Biology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:107297 |
| institution | FRELIP |
| journal_source_facet | Biologics: Targets & Therapy |
| last_indexed | 2026-07-28T03:36:58.848Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Safety Profile of Tozorakimab (an Anti-IL-33 Monoclonal Antibody): Data from the FRONTIER Phase 2 Program Biology General Biology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Biology General Biology |
| subject_facet | Biology General Biology |
| title | Safety Profile of Tozorakimab (an Anti-IL-33 Monoclonal Antibody): Data from the FRONTIER Phase 2 Program |
| title_alt | Perfil de seguridad de Tozorakimab (un anticuerpo monoclonal anti-IL-33): Datos del programa FRONTIER Fase 2 Profil de sécurité du tozorakimab (un anticorps monoclonal anti-IL-33) : données du programme de phase 2 FRONTIER Perfil de Segurança de Tozorakimab (um Anticorpo Monoclonal Anti-IL-33): Dados do Programa FRONTIER Fase 2 |
| title_auth | Safety Profile of Tozorakimab (an Anti-IL-33 Monoclonal Antibody): Data from the FRONTIER Phase 2 Program |
| title_es_txt | Perfil de seguridad de Tozorakimab (un anticuerpo monoclonal anti-IL-33): Datos del programa FRONTIER Fase 2 |
| title_fr_txt | Profil de sécurité du tozorakimab (un anticorps monoclonal anti-IL-33) : données du programme de phase 2 FRONTIER |
| title_full | Safety Profile of Tozorakimab (an Anti-IL-33 Monoclonal Antibody): Data from the FRONTIER Phase 2 Program |
| title_fullStr | Safety Profile of Tozorakimab (an Anti-IL-33 Monoclonal Antibody): Data from the FRONTIER Phase 2 Program |
| title_full_unstemmed | Safety Profile of Tozorakimab (an Anti-IL-33 Monoclonal Antibody): Data from the FRONTIER Phase 2 Program |
| title_pt_txt | Perfil de Segurança de Tozorakimab (um Anticorpo Monoclonal Anti-IL-33): Dados do Programa FRONTIER Fase 2 |
| title_short | Safety Profile of Tozorakimab (an Anti-IL-33 Monoclonal Antibody): Data from the FRONTIER Phase 2 Program |
| title_sort | safety profile of tozorakimab (an anti-il-33 monoclonal antibody): data from the frontier phase 2 program |
| topic | Biology General Biology |
| url | https://www.dovepress.com/safety-profile-of-tozorakimab-an-anti-il-33-monoclonal-antibody-data-f-peer-reviewed-fulltext-article-BTT |